Sanara MedTech Inc (SMTI)
32.05
-0.39
(-1.20%)
USD |
NASDAQ |
May 06, 13:05
Sanara MedTech Free Cash Flow: -3.511M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.511M |
| September 30, 2023 | -3.306M |
| June 30, 2023 | -4.402M |
| March 31, 2023 | -5.914M |
| December 31, 2022 | -6.302M |
| September 30, 2022 | -7.530M |
| June 30, 2022 | -9.345M |
| March 31, 2022 | -6.456M |
| December 31, 2021 | -5.565M |
| September 30, 2021 | -4.717M |
| June 30, 2021 | -3.411M |
| March 31, 2021 | -4.355M |
| December 31, 2020 | -5.679M |
| September 30, 2020 | -5.95M |
| June 30, 2020 | -6.497M |
| March 31, 2020 | -6.019M |
| December 31, 2019 | -3.873M |
| September 30, 2019 | -2.438M |
| June 30, 2019 | -0.9929M |
| March 31, 2019 | 0.0275M |
| December 31, 2018 | 0.2687M |
| September 30, 2018 | 0.4955M |
| June 30, 2018 | 0.0042M |
| March 31, 2018 | -0.1491M |
| December 31, 2017 | -0.2257M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.1186M |
| June 30, 2017 | 0.4559M |
| March 31, 2017 | 0.2648M |
| December 31, 2016 | 0.4062M |
| September 30, 2016 | -0.2162M |
| June 30, 2016 | -0.8895M |
| March 31, 2016 | -1.165M |
| December 31, 2015 | -1.208M |
| September 30, 2015 | -1.320M |
| June 30, 2015 | -1.201M |
| March 31, 2015 | -1.188M |
| December 31, 2014 | -1.695M |
| September 30, 2014 | -2.017M |
| June 30, 2014 | -1.859M |
| March 31, 2014 | -1.898M |
| December 31, 2013 | -1.822M |
| September 30, 2013 | -1.109M |
| June 30, 2013 | -1.425M |
| March 31, 2013 | -1.180M |
| December 31, 2012 | -1.226M |
| September 30, 2012 | -1.063M |
| June 30, 2012 | -1.017M |
| March 31, 2012 | -1.124M |
| December 31, 2011 | -0.3436M |
| September 30, 2011 | -0.8299M |
Free Cash Flow Range, Past 5 Years
-9.345M
Minimum
Jun 2022
-0.9929M
Maximum
Jun 2019
-5.066M
Average
-5.565M
Median
Dec 2021
Free Cash Flow Benchmarks
| AptarGroup Inc | 253.68M |
| Daxor Corp | -- |
| Precision Optics Corp Inc | -1.777M |
| Warby Parker Inc | 7.32M |
| Perspective Therapeutics Inc | -37.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.8485M |
| Cash from Investing (Quarterly) | -0.0543M |
| Cash from Financing (Quarterly) | -0.1859M |
| Free Cash Flow Per Share (Quarterly) | -0.1077 |
| Free Cash Flow to Equity (Quarterly) | -0.9059M |
| Free Cash Flow to Firm (Quarterly) | -0.6153M |
| Free Cash Flow Yield | -1.32% |